2011 Scrip 100: Nothing is certain except change
This article was originally published in Scrip
Executive Summary
Concerns over the lack of innovation in the pharmaceutical industry have been rumbling for some time, but one recently reported fact provides new grist for this mill: for the first time ever there were no new drug targets reported at this year's American Chemical Society (ACS) meeting.